| The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ... Annals of Oncology 24 (2), 454-462, 2013 | 344 | 2013 |
| Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer AA Argyriou, G Cavaletti, C Briani, R Velasco, J Bruna, M Campagnolo, ... Cancer 119 (2), 438-444, 2013 | 261 | 2013 |
| Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ... Annals of oncology 25 (1), 257-264, 2014 | 174 | 2014 |
| Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study AA Argyriou, G Cavaletti, A Antonacopoulou, AA Genazzani, C Briani, ... Cancer 119 (19), 3570-3577, 2013 | 130 | 2013 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 122 | 2017 |
| Long‐term course of oxaliplatin‐induced polyneuropathy: a prospective 2‐year follow‐up study C Briani, AA Argyriou, C Izquierdo, R Velasco, M Campagnolo, P Alberti, ... Journal of the Peripheral Nervous System 19 (4), 299-306, 2014 | 104 | 2014 |
| Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) D Binda, EK Vanhoutte, G Cavaletti, DR Cornblath, TJ Postma, B Frigeni, ... European journal of cancer 49 (13), 2910-2918, 2013 | 58 | 2013 |
| Peripheral nervous system involvement in lymphomas C Briani, A Visentin, M Campagnolo, A Salvalaggio, S Ferrari, T Cavallaro, ... Journal of the Peripheral Nervous System 24 (1), 5-18, 2019 | 57 | 2019 |
| Symptom recognition is impaired in patients with orthostatic hypotension R Freeman, BMW Illigens, R Lapusca, M Campagnolo, AR Abuzinadah, ... Hypertension 75 (5), 1325-1332, 2020 | 54 | 2020 |
| Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers A Salvalaggio, D Coraci, M Cacciavillani, L Obici, A Mazzeo, M Luigetti, ... Journal of Neurology 268, 189-198, 2021 | 46 | 2021 |
| Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function? S Rajan, M Campagnolo, B Callaghan, CH Gibbons Clinical Autonomic Research 29, 31-39, 2019 | 45 | 2019 |
| Advanced age and liability to oxaliplatin‐induced peripheral neuropathy: post hoc analysis of a prospective study AA Argyriou, C Briani, G Cavaletti, J Bruna, P Alberti, R Velasco, ... European Journal of Neurology 20 (5), 788-794, 2013 | 45 | 2013 |
| The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy F Castellani, A Visentin, M Campagnolo, A Salvalaggio, M Cacciavillani, ... Neurology: Neuroimmunology & Neuroinflammation 7 (4), e720, 2020 | 43 | 2020 |
| Genetic determinants of chronic oxaliplatin‐induced peripheral neurotoxicity: a genome‐wide study replication and meta‐analysis S Terrazzino, AA Argyriou, S Cargnin, AG Antonacopoulou, C Briani, ... Journal of the Peripheral Nervous System 20 (1), 15-23, 2015 | 43 | 2015 |
| Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias C Briani, GM Fabrizi, S Ruggero, CD Torre, M Ferrarini, M Campagnolo, ... Muscle & nerve 43 (2), 164-167, 2011 | 43 | 2011 |
| Nerve ultrasound findings in neuropathy associated with anti‐myelin‐associated glycoprotein antibodies M Lucchetta, L Padua, G Granata, M Luigetti, M Campagnolo, ... European Journal of Neurology 22 (1), 193-202, 2015 | 38 | 2015 |
| Ultrasound assessment of oxaliplatin‐induced neuropathy and correlations with neurophysiologic findings C Briani, M Campagnolo, M Lucchetta, M Cacciavillani, C Dalla Torre, ... European journal of neurology 20 (1), 188-192, 2013 | 38 | 2013 |
| Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment M Campagnolo, S Ferrari, C Dalla Torre, I Cabrini, M Cacciavillani, ... Journal of Neuroimmunology 281, 1-4, 2015 | 37 | 2015 |
| Lenalidomide long-term neurotoxicity: clinical and neurophysiologic prospective study C Dalla Torre, R Zambello, M Cacciavillani, M Campagnolo, T Berno, ... Neurology 87 (11), 1161-1166, 2016 | 34 | 2016 |
| Diagnostic criteria for idiopathic small fiber neuropathy: a systematic review S Haroutounian, MS Todorovic, M Leinders, M Campagnolo, ... Muscle & Nerve 63 (2), 170-177, 2021 | 33 | 2021 |
